washing, anti-la-treated cells were resuspended in 1:20 rabbit complement (C) and anti-Lyttreated cells were resuspended in 1:6 guinea pig C and incubated for 10 min at 4°C and then 30 min at 37°C. The washed cells were then resuspended in RPMI medium at l0 s cells/ml and treated with hapten.
Purification of T Cells. Lymph node T cells were purified on nylon wool according to the method of Julius et al. (31) . 4-5 × 10 s LN cells in 1.0 ml were washed into 1.5-2.0-g nylon wool columns with warm medium, and the columns were incubated at 37°C. After 20 min incubation, the cells were slowly moved down the column by allowing 0.5-1 ml of medium to pass through. The column was replaced at 37°C and after an additional 20 min incubation, the above procedure was repeated. After a total incubation period of 60 min at 37°C, nonadherent cells were collected by washing the column slowly with 25-30 ml of warm medium. The eluted cells were washed and resuspended at l0 s cells/ml in RPMI medium. The nonadherent T cells were monitored for B cell contamination by immunofluorescent staining with fluorescein-labeled polyvalent rabbit anti-mouse Ig and for macrophage contamination by esterase staining. In the experiments reported here (Table III and VIII), the T cell populations contained a maximum of 1% B cells and <1% macrophages.
Results

Dose-dependent Inhibition by DNP-Lysine of Transfer of CS.
To determine whether soluble hapten would interfere with transfer of CS, DNFB-immune LN cells were incubated for 1 h at 4°C with different concentrations of monovalent DNP-lysine. The cells were then washed to remove free hapten and 5 × 107 cells injected intravenously into each of four syngeneic recipients. These animals were then ear challenged, and ear swelling was measured 24 h later. Results of two experiments are given in Table I and show a dose-dependent inhibition by DNP-lysine of transfer of CS to DNFB. Similar inhibition curves have been obtained using DNP-glycine, DNPI1-MGG, DNPIs-BSA, and DNP~a-RGG (not shown).
Specificity of Hapten-mediated Inhibition of Transfer of Immunity.
To test the specificity of inhibition, we compared various DNP-, TNP-, and NIP-protein conjugates. The treatment protocol was the same. Immune LN cells (10a/ml) in RPMI medium were BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested on day 4. The cells were resuspended in RPMI 1640 medium at 10 s cells/ml and treated with different doses of DNP-lysine for 1 h at 4°C. The cells were then washed three times and transferred to normal syngeneic recipients that were ear challenged with DNFB. Increased ear swelling was measured 24 h later as an index of transfer of CS. * Ear swelling in recipients of immune LN cells minus ear swelling in negative controls (ear challenge only). :~ P < 0.05. § P < 0.001.
TABLE I
Dose-dependent Inhibition by DNP-Lysine of Transfer of CS to DNFB
Group
treated for 1 h at 4°C by the addition of 1 /tg/ml of the particular hapten-protein conjugate. A group of cells treated with 1 gg/ml DNP-lysine was included in all experiments for comparison. After washing, 5 × 107 cells were injected intravenously into naive recipients that were then ear challenged, and ear swelling was measured 24 h later. Representative results of several replicate experiments are given in Fig. 1 . In experiment I, pretreatment of the immune LN cells with either DNP-lysine or DNPla-MGG inhibited the transfer of immunity by >60% (compare groups B and C with A), whereas treatment of the LN cells with NIPa-MGG had no effect (compare groups D and A). Similar results were obtained in experiment II where DNP-and TNP-protein conjugates were compared. Pretreatment with DNP-lysine, DNPa~-BSA, or DNP29-RGG inhibited transfer by 75% or more (compare groups B, C, and E with A). In contrast, treatment with TNP19-BSA or TNP24-RGG caused no significant inhibition (compare groups D and F with A).
To examine the specificity of inhibition in a more critical way, the following experiment was done. BALB/c mice were doubly sensitized with DNFB and Ox (see Materials and Methods). A single cell suspension of pooled LN was prepared, diluted to 10 s cells/ml, and divided into two tubes. One tube received 1 #g/ml DNP-lysine and the other received an equal amount of lysine. After 1 h at 4°C, 5 × 107 washed cells were injected intravenously into normal syngeneic recipients. Half of the recipients that received control lysine-treated LN cells and half that received DNP-lysinetreated cells were ear challenged with DNFB. The remaining recipients were ear challenged with Ox. Increased ear swelling was measured 24 h later. Results of two such experiments are given in Table II . Transfer of contact sensitivity to DNFB by LN cells from the doubly sensitized mice was inhibited by treating the cells with DNP-lysine (compare group B with A). In contrast, the ability of these same LN cells to transfer contact sensitivity to Ox was unaffected by the DNP-lysine treatment (compare groups C and D). Collectively, these results indicate that the inhibition of transfer of CS by treating immune LN cells with DNP-lysine or DNP-protein conjugates is hapten specific. Furthermore, the results in Table II show that the 1-h Ft¢. 1. Hapten specificity of inhibition of transfer of immunity. BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested on day 4. The cells were suspended in RPMI medium at 10 s cells/ml and treated for t h at 4°C with either DNP-lysine or different DNP-, NIP-, or TNP-protein conjugates. The ceils were then washed three times and 5 × 107 cells transferred intravenously into normal recipients (four per group). The recipients were ear challenged with DNFB, and ear swelling was measured 24 h later. * P < 0.01. (27) . Thus, experiments were done to determine whether purified Ia-T cells were hapten inhibitable. Results of these experiments are given in Table III . In experiment I, unseparated and nylon wool-purified DNFB-immune BALB/c LN T cells were compared. Both cell populations transferred similar levels of immunity and both were sensitive to inhibition by the hapten. In experiment II, purified LN T cells from DNFB-immune CBA mice were treated with normal mouse serum or anti-Ia k serum plus C and then tested for their sensitivity to inhibition by hapten. Antiserum treatment did not alter either the ability of the cells to transfer immunity or their sensitivity to inhibition by DNP-lysine. These results indicate that inhibition of transfer of immunity is mediated by interaction of the hapten DNP with the effector T cells of the CS reaction.
A Ear Swelling
TASLE II
Hapten-mediated Inhibition of Transfer of Immunity Is Not due to Activation of Suppressor Cells. Skin painting of mice with DNFB induces at least two distinct T cell subpopulations: effector T cells of the CS reaction (Ton) and auxiliary suppressor T cells (Ts-aux) (32) . This latter population is required for suppression of the efferent limb of CS by suppressor T cells (32) . Because the immune LN cells contain both T cell subsets, it was possible that inhibition of transfer of immunity was due to activation of Ts-aux cells by the hapten. To test this possibility, cotransfer experiments were done. Immune LN cells were prepared and a portion treated with DNP-lysine. After washing, half of the treated cells were injected intravenously into naive recipients (5 × 107/recipient). The remaining cells were mixed with untreated immune LN cells (1:1) and 10 s cells injected into nai've recipients. A third group of recipients received 5 × 107 untreated immune LN cells. All mice were then ear challenged, and ear swelling was measured 24 h later. As shown in Table IV , cotransfer of DNP-lysine- BALB/c (experiment I) or CBA (experiment II) mice were sensitized with DNFB on days 0 and l, and immune LN cells, harvested on day 4. In experiment I, a portion of the cells were purified on nylon wool colunms. Unseparated and purified T cells were suspended in RPMI 1640 medium at 108 cells/ml, and half of each population were treated with 1 ~g/ml DNP-lysine for 1 h at 4°C. The cells were then washed three times and transferred to normal syngeneic recipients. * See footnote in Table I . :]: 1 #g/ml lysine. § P < 0.001. ]] Normal mouse serum. ¶ Anti-la k serum. BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells were harvested on day 4. The cells were suspended in RPMI 1640 medium at 108 cells/ml and a portion treated with 1 #g/nd DNP-lysine for 1 h at 4°C. These cells were then washed three times, and half were injected into normal syngeneic recipients. The remaining cells were mixed with an equal number of untreated immune LN cells, and the mixture injected into normal syngeneic recipients. An additional group of recipients received only untreated immune cells. All animals were ear challenged, and increased ear swelling was measured 24 h later as an index of transfer of immunity. * See footnote in Table I . :~ P < o.00 I. treated cells with untreated immune cells had no effect on the ability of the latter population to transfer immunity.
TABLE IV
DNP-Lysine Inhibition of Transfer of CS to DNFB Is Not Due to Suppressor Cells
To further test for the possible role of suppressor T cells, the following experiment was done. Immune LN cells were prepared, and four replicate tubes were treated with monoclonal anti-Lyt-2.2 antibody plus C. The washed cells were resuspended at l0 s cells/ml in RPMI medium, treated for 1 h at 4°C with lysine or DNP-lysine, and then tested for their ability to transfer CS. Results of two experiments are given in Table V and show that anti-Lyt-2.2 plus C treatment did not alter the sensitivity of the LN cells to inhibition by DNP-lysine. These results indicate that DNP-lysine inhibition of transfer of CS is not due to activation of suppressor cells.
Effect of Temperature, Time of Treatment, and Divalent Cations on DNP-Lysine Inhibition.
Certain in vitro conditions have been found to be critically important for studying T cell interaction with antigen. Thus, experiments were done to determine the minimal in vitro conditions necessary for DNP-lysine-mediated inhibition of transfer. Three parameters were examined and representative results are given in Table VI . First, the temperature during the incubation period was tested. Immune LN cells (10 s cells/mi) were incubated with 1 #g/ml DNP-lysine for 1 h at 4 °, 22 °, and 37°C. Lysine-treated cells were incubated at 37°C. After washing, the cells were tested for their ability to transfer CS. As shown in experiment I, incubation temperature had no effect on the ability of DNP-lysine to inhibit transfer of immunity. Next, we determined the minimum amount of time necessary to treat the cells. Replicate tubes of immune LN cells (10 s cells/ml) were treated with 1 #g/ml DNP-lysine at 4°C for 15, 30, or 60 min, washed, and 5 × 107 cells transferred to naive recipients. As shown in experiment II, significant inhibition of transfer was obtained by treating the cells for only 15 min (compare group B to A). Finally, we examined the requirement for divalent cations. Immune LN cells were suspended in HBSS or in Ca ++, Mg++-free HBSS at l0 s cells/ml and treated for 1 h at 4°C with 1 #g/ml DNP-lysine. Control cells were treated with lysine and incubated in Ca ++, Mg++-free HBSS. After washing, 5 × 107 cells per recipient were transferred to nai've recipients, and ear swelling was measured 24 h later. As shown in experiment III, transfer to CS by immune LN cells treated BALB/c mice were sensitized were DNFB on days 0 and 1 and immune LN cells were harvested on day 4. In experiments I and II the cells were suspended in RPMI 1640 medium at 10 s cells/ml and treated with 1 #g/ml DNP-lysine or lysine as indicated. In experiment III cells were suspended in HBSS or Ca ++, Mg++-free HBSS at 10 a cells/ml and treated with 1 #g/ml DNP-lysine or lysine for 1 h at 4°C. In all three experiments, after treatment the cells were washed three times and transferred to ha'ire recipients that were then ear challenged. Increased ear swelling was measured 24 h later as an index of transfer of immunity. * See footnote in Table I . ~: P< 0.001. § P < 0.05.
with DNP-lysine in Ca ++, Mg++-free HBSS was not inhibited (compare group C to A), whereas the transfer by cells treated in HBSS containing divalent cations (group B) was inhibited by 80%. Collectively, these results indicate that the interaction of DNP-lysine with immune LN T cells in vitro is rapid, temperature independent, and requires the presence of divalent cations in the treatment medium.
DNP-Lysine Inhibition of DNFB-immune T Cells Is Reversible.
To begin to explore the mechanism of the hapten inhibition, two possibilities were considered. First, the hapten may bind to receptors for DNP and block the T cell from interacting with immunogenic forms of DNP in association of MHC gene products, i.e., receptor blockade. Alternatively, interaction with hapten alone may provide some negative signal to the T cell, making it refractory to stimulation. If so, the cells should not become functional after a short incubation period in vitro in hapten-free medium. However, if inhibition is due to hapten blocking the receptor, then incubation in vitro may reverse the effect by allowing the hapten to dissociate from the cell surface. To attempt to distinguish between these two possibilities, the following experiment was done. Four replicate tubes of immune LN cells were treated with DNP-lysine in vitro according to the standard protocol. After washing, one group of cells was injected intravenously into syngeneic recipients. The remaining cells were resuspended in RPMI medium and incubated at 37°C for 1 h. These cells were then washed and one group was injected intravenously into syngeneic recipients. The remaining two tubes of cells were resuspended in RPMI medium, placed at 4°C, and one tube was again treated with 1 #g/ml of DNP-lysine. After 1 h incubation, these cells were washed and transferred to na'ive recipients. Control, lysine-treated immune cells were carried through all three incubation periods and then injected into recipient mice. All recipients were then ear challenged, and ear swelling was measured 24 h later. The results are given in Table VII . Immune LN cells treated for 1 h with DNP-lysine and then transferred were inhibited (compare group B to A). This inhibition was reversed by incubating the treated cells for 1 h at 37°C in hapten-free medium (compare group C with A and B). However, if similarly treated cells were reincubated at 4°C for 1 h and retreated with DNP-lysine, their ability to transfer immunity was once again inhibited (compare group E to A and D). These results favor the interpretation that the inhibition is mediated by hapten binding to the T cell receptors thus blocking the cell from interacting with antigen-presenting cells at the skin test site.
Additional experiments have shown that this reversal of inhibition is temperature independent, i.e., reversal occurs if the treated cells are incubated for 1 h in haptenfree medium at 4 °, 25 °, or 37°C. Also, we have found that addition of fetal calf serum (FCS) to the hapten-free medium retards the reversal in a concentrationdependent way. In other words, hapten-treated immune LN cells incubated for 1 h at 37°C in hapten-free medium containing 20% FCS are still inhibited by 50% or more, whereas cells incubated in medium containing 10 or 5% FCS are progressively less inhibited (data not shown). BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested on day 4. The cells were suspended in RPMI 1640 medium at l0 s cells/ml and aliquoted into five replicate tubes. Cells in tube A were carried through all three l-h incubations and treated with 1 #g/ml lysine as indicated. Tubes B-E were initially treated with 1 #g/ml DNP-lysine at 4°C and washed. Cells in tube B were then injected intravenously into syngeneic recipients. Cells in tubes C-E were resuspended in RMPI 1640 medium, incubated for 1 h at 37°C, and washed. Cells in tube C were then injected into syngeneic recipients. Cells in tubes D and E were then resuspended in RPMI 1640 medium, 1 ~g/ml DNP-lysine added to tube E, and the two tubes incubated for 1 h at 4°C. After washing, these cells plus the cells from tube A were injected intravenously into three groups of syngeneic recipients. All recipients were then ear challenged with DNFB, and increased ear swelling was measured 24 h later. * See footnote in Table I . :~ P < 0.001. (33) . Suppressive immune serum (SIS) which contains these antibodies is obtained by bleeding DNFB-immune mice 9-15 d after sensitization. Treatment of immune LN cells with SIS plus C eliminates transfer of CS to DNFB but has no effect on transfer of immunity to TNCB or Ox. Similarly, the anti-idiotype activity of SIS is removed by adsorption with DNFB-immune LN ceils but not by TNCB-or Ox-immune cells (33) . We used this adsorbing ability of DNFB-immune LN cells to determine whether DNP-lysine and anti-idiotypic antibodies were binding to the same sites on the immune T cells. The following protocol was used. Nylon wool-purified or unseparated immune LN cells were treated in vitro for 1 h at 4°C with hapten. After washing, 2 × 10 a treated or control cells were used to adsorb 2 ml of 1:2 diluted SIS for 30 min at 4°C. To test for remaining anti-idiotype activity, freshly prepared DNFB-immune LN cells were then treated with adsorbed or unadsorbed SIS plus C and transferred to naive recipients. These animals were ear challenged, and ear swelling was measured 24 h later. Results of these experiments are shown in Table VIII . Two different pools of SIS were used in the two experiments shown. In experiment I, untreated and DNPlysine-treated nylon wool-purified DNFB-immune LN T cells were compared for their ability to adsorb SIS. Unadsorbed SIS plus C inhibited transfer of immunity by 71% (compare group B to A), whereas serum adsorbed with lysine-treated LN T cells inhibited transfer by only 12% (compare group C to A). In contrast, serum adsorbed with DNP-lysine-treated T cells inhibited transfer by 68% (group D vs. A). Thus, DNP-lysine treatment of the T cells blocked their ability to adsorb the activity of the SIS. In experiment II, the specificity of the inhibition of adsorption was tested by comparing immune LN cells treated with DNP-lysine, DNPn-MGG, or NIPg-MGG. This SIS was somewhat less active as the unadsorbed serum plus C inhibited transfer BALB/c mice were sensitized with DNFB on days 0 and 1, and immune LN cells harvested on day 4. The cells were resuspended in RPMI 1640 medium at 10 s cells/ml and treated with 1 #g/ml lysine, DNP-lysine, DNPn-MGG, or NIPa-MGG. After washing, these cells were used to adsorb 2 ml of 1:2 SIS for 30 min at 4°C. Freshly prepared DNFB-immune LN cells were then treated with the adsorbed or unadsorbed SIS plus C and transferred to normal recipients. The recipients were ear challenged with DNFB, and increased ear swelling was measured 24 h later. * See footnote in Table I by only 41% (group B vs. A). Nevertheless, adsorption of this serum with lysinetreated immune LN cells completely removed the inhibitory activity (group C vs. A), and this adsorption was blocked by treating the immune LN cells with either DNPlysine or DNPn-MGG (groups D and E). However, treating the immune cells with NIPg-MGG had no effect as these cells completely adsorbed the inhibitory activity of the SIS (group F). These results indicate that DNP-lysine and the anti-idiotypic antibodies compete for the same binding sites on the DNFB-immune T cells. Discussion Exactly how T cells "see" antigen still is poorly understood. It seems clear that for activation of T cells, the cells must interact with antigen in the context of certain MHC determinants expressed on the surface of antigen-presenting cells or target cells (7) . The molecular nature of this interaction, i.e., the type(s) of receptor(s) used by the T cells, is unknown. In the present study, I have investigated the first phase of T cell-antigen interaction by treating DNFB-immune T cells in vitro with free hapten or hapten-protein conjugates. The effect(s) of this treatment was measured by testing the ability of the treated cells to transfer CS to DNFB into na'/ve recipients. The experimental results establish the following points: (a) incubation of DNFB-immune LN cells or purified T cells in vitro with E-DNP-L-lysine or DNP-protein conjugates inhibits, in a dose-dependent way, the transfer of CS; (b) the inhibition is hapten specific and is not due to toxic effects of the hapten; (c) the inhibition is not mediated by activation of suppressor cells; (d) inhibition of the T cells by hapten in vitro, presumably reflecting their interaction, is rapid and temperature independent but requires divalent cations; (e) inhibition is reversed by incubating the treated cells for 1 h in vitro in hapten-free medium. If these cells are retreated with hapten, transfer of immunity is again blocked; and (f) hapten-treated T cells are unable to adsorb specific anti-idiotype antibody, and this inhibition of adsorption is hapten specific.
Competition of DNP-Lysine and Anti-Idiotype Antibodies for Binding Sites on DNFB-immune T Cells. Previous studies from our laboratory have shown that the duration of the CS response to DNFB is regulated by anti-idiotype antibodies produced by the host
CS to DNFB is mediated by Ia-T cells (Toll) (27) . The finding here that transfer of CS by purified, Ia-T cells, carefully monitored for macrophage and B cell contamination, is blocked by monovalent hapten indicates that the Ton cells interact with the hapten. This is supported by the experiments which showed that activation of suppressor cells was not responsible for the inhibition. Thus, it appears that the inhibition of transfer of immunity is due to direct interaction of the effector Tt, H population with the hapten and does not require or involve other cell types.
These findings differ from most other studies that have attempted to block T cell function with free antigen. For example, lysis of chromium-labeled target cells by virus-or hapten-specific cytotoxic T cells is not inhibited by unmodified cold target cells, virus-infected, or hapten-labeled allogeneic cells or by addition of free hapten (18, 20, 22, 26) . Similarly, free antigen does not inhibit T cell proliferation in vitro or the binding of immune T cells to antigen-pulsed macrophages (19, 21, (23) (24) (25) . These negative findings are somewhat surprising in light of studies that have shown T cell binding of soluble radiolabeled antigen (34) (35) (36) (37) . It is difficult to reconcile these apparently contradictory results, although it is possible that the T cells that bind soluble radiolabeled antigen do not belong to the same functional subset being stimulated or analyzed. Alternatively, the closed, in vitro conditions used to measure most T cell functions and that are almost always optimized, may so favor T cell activation that functional inhibition of the cells by free antigen may be extremely difficult. In other words, if only a limited number of contacts (one or two perhaps) between the T cell and antigen-presenting cell or target cell are required for stable T cell binding and activation, these interactions may occur with time in vitro even in the presence of a large excess of antigen. Thus, our ability to inhibit CS by treating T cells with monovalent hapten may reflect, in part, the fact that we test the function of the cells in vivo rather than in vitro. Indeed, previous studies by Kantor (38) and Leskowitz and Jones (39) have shown that delayed hypersensitivity reactions are inhibited either by treating cells in vitro with highly substituted hapten-protein conjugates and then transferring the cells, or by injecting immune animals with hapten-amino acid or hapten-protein conjugates.
The interaction of T cells with hapten in vitro, as measured by inhibition of transfer of immunty, is rapid, temperature independent, and requires divalent cations in the incubation medium. Furthermore, the inhibition is reversed by incubating the treated cells for 1 h in hapten-free medium (see below). Our finding that 15-30 min incubation time is required to achieve inhibition of transfer is in agreement with other reports that have investigated T cell binding of radiolabeled antigen (34, 36, 37) . However, these studies have found that significant binding occurs only at 37°C, whereas our results indicate that the temperature of incubation has no effect on the level of inhibition caused by the hapten. At present we have no explanation for this difference. The requirement for divalent cations is of particular interest since this aspect has been studied in a variety of other systems. For example, divalent cations have been shown to be required for adherence of cytotoxic T cells to target cells (40) , for antigen-independent and antigen-dependent binding of lymphocytes to macrophages (41, 42) , and for maintenance of antigen-dependent binding of-T cells to macrophages (42) . It has been suggested that divalent cations serve to form ionic bridges between cells, thus providing stable interaction at the membrane interface. The results presented here, however, indicate that divalent cations are required for the inactivation of TDH cells by monovalent DNP-lysine without the participation of other cell types. The precise role the cations play in this process is unknown; it seems unlikely to involve ionic bridges between cells. One possible alternative explanation is that they serve to stabilize the antigen receptor in the T cell membrane, perhaps by maintaining the proper stereoconfiguration of subunits. This effect would be similar to Ca+*-dependent antigen-antibody reactions that are due to antibodies directed against determinants formed and/or maintained by Ca++-induced alterations of the antigen (43) . We are unaware of any studies of the divalent cation requirements for binding of radiolabeled antigen to T cells. We are currently studying this and other aspects of the hapten-T cell interaction.
The reversible nature of the hapten-inhibition in vitro at first presented a paradox since the inhibition is still present 24 h after the washed cells are transferred intravenously to nai've recipients. We believe, however, that the situation is clarified by our recent experiments which show that addition of serum to the incubation medium maintains the inhibited state. It appears that high protein concentration, i.e., 20% or more FCS, favors the continued association of the hapten with the T cells, whereas low or no protein favors dissociation. Thus intravenously injected cells would be suspended in the plasma equivalent of 100% serum that would maintain the hapten binding and would account for the inhibited response.
The experiments that showed hapten-specific blocking of T cell adsorption of anti-idiotype antibody provide critical information with respect to the mechanism of hapten-inhibition of transfer of immunity. These results indicate that the hapten and the anti-idiotype antibody compete for the same site on the TDa cell. Since both of these reagents are hapten specific in their effect, this site is most likely the antigenspecific receptor for DNP. Krammer (44) has reported similar findings for alloantigenbinding T cells. It follows then that the inhibition of transfer of CS is due to DNPbinding to the hapten-specific receptor on the T cell. It is likely that this binding prevents the T cells from interacting with immunogenic forms of the hapten, i.e., DNP plus MHC determinants, at the skin test site. This binding may be of relatively low affinity since the inhibition is reversed by incubating the treated cells in vitro for 1 h in hapten-free medium. We believe this reversal is due to dissociation of the hapten rather than shedding of receptors, because it occurs at 4°C and the cells are inhibited again by reincubation with hapten. It is unlikely that any significant receptor shedding or re-expression would occur at 4°C. Finally, in a recent article discussing T cell recognition of antigen, it was suggested that five criteria be met before T cells could be characterized as hapten specific (17) . Although these criteria were written with respect to activation of T ceils, they are equally applicable to inhibition of T cells and are restated in this context as follows: T cells may be characterized as hapten specific if (a) cells are inhibited by the same hapten on different carriers; (b) carrier alone does not inhibit the cells; (c) a different hapten on the same carrier does not inhibit the ceils; (d) free hapten can inhibit the response; and (e) cells are inhibited by the hapten coupled via spacer molecules to the carrier. The results presented here satisfy the first four of these five criteria and so the T cells that mediate CS to DNFB can be termed hapten specific. Furthermore, these results provide strong evidence that in this hapten-specific TDa population, and regardless of other receptors, antigen recognition occurs via a receptor specific for the hapten DNP. These findings make the altered self model less likely, unless the one receptor that this model proposes and that is specific for a neoantigenic determinant still can recognize hapten alone.
Summary
Experiments were done to investigate the nature of the antigen receptor on lymph node (LN) T cells from mice sensitized to 2,4-dinitrofluorobenzene (DNFB). LN cells or purified T cells were treated in vitro with monovalent or different multivalent 2,4-dinitrophenol (DNP) ligands. The effect of this treatment was measured by testing the ability of the cells to transfer contact sensitivity (CS) to DNFB into na'ive recipients. We found that treatment of the T cells in vitro with either ~-DNP-L-lysine or DNP-protein conjugates inhibits the transfer of CS in a dose-dependent way. The inhibition is hapten specific and is not mediated by activation of suppressor cells. Inhibition of the T cells by hapten in vitro is rapid (15-30 min) and temperature independent but requires divalent cations in the treatment medium. In addition, it was found that hapten-treated T cells are unable to adsorb specific anti-idiotype antibody, and this inhibition of adsorption is hapten specific. Collectively, these data indicate that DNFB-immune T cells express a receptor specific for the hapten DNP and provide evidence that supports a two-receptor model for T cell recognition of antigen.
